<DOC>
	<DOCNO>NCT02539849</DOCNO>
	<brief_summary>FOS improve gut colonization Faecalibacterium prausnitzii patient Crohn 's disease</brief_summary>
	<brief_title>Effect Prebiotic FOS Intestinal Abundance Faecalibacterium Prausnitzii Patients With CrohnÂ´s Disease</brief_title>
	<detailed_description>To demonstrate FOS increase count Faecalibacterium prausnitzii faecal sample Crohn 's disease patient</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Patients 18 65 year old Crohn 's disease patient Inflammatory activity confirm image technique ( colonoscopy magnetic resonance imaging ( MRI ) ) Refractory inflammatory luminal disease ( without perianal involvement ) level gastrointestinal tract require therapy adalimumab , accord standard clinical practice . Stable maintenance medication ( corticosteroid / immunosuppressant and/or 5aminosalicylic acid ( 5ASA ) ) past 4 week Screening test require safe administration anti tumour necrosis factor ( antiTNF ) antibody perform accord standard clinical practice Subjects consume prebiotic supplement ( inulin , FOS , galactooligosaccharides ( GOS ) ) regular diet . Antibiotic use within past 2 month Previous antiTNF therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>